AZZONI, Cinzia
 Distribuzione geografica
Continente #
NA - Nord America 1.434
EU - Europa 1.234
AS - Asia 636
AF - Africa 11
OC - Oceania 2
Totale 3.317
Nazione #
US - Stati Uniti d'America 1.412
CN - Cina 505
IE - Irlanda 316
SE - Svezia 255
FI - Finlandia 195
IT - Italia 181
UA - Ucraina 98
DE - Germania 85
SG - Singapore 55
TR - Turchia 42
AT - Austria 38
CA - Canada 22
IN - India 22
GB - Regno Unito 21
BE - Belgio 19
CI - Costa d'Avorio 10
FR - Francia 8
CZ - Repubblica Ceca 7
IR - Iran 5
NL - Olanda 4
HK - Hong Kong 3
RU - Federazione Russa 3
AU - Australia 2
VN - Vietnam 2
ES - Italia 1
GR - Grecia 1
KZ - Kazakistan 1
PT - Portogallo 1
RO - Romania 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 3.317
Città #
Chandler 357
Dublin 316
Jacksonville 110
Dearborn 105
Ashburn 101
Ann Arbor 92
Beijing 81
Shanghai 77
Parma 71
Nanjing 69
Princeton 48
New York 45
Izmir 42
Vienna 38
Jinan 36
Wilmington 30
Singapore 28
San Mateo 27
Shenyang 26
Tianjin 22
Boardman 20
Nanchang 19
Bremen 18
Seattle 18
Toronto 18
Changsha 17
Hebei 17
Hefei 16
Helsinki 16
Los Angeles 16
Woodbridge 16
Kunming 14
Brussels 13
Chicago 12
Pune 12
Des Moines 11
Abidjan 10
Guangzhou 10
Hangzhou 10
Rio Saliceto 8
Bologna 7
Haikou 7
Ningbo 7
Zhengzhou 7
Jiaxing 6
Louvain-la-Neuve 6
Norwalk 6
Taiyuan 6
Lanzhou 5
Taizhou 5
Auburn Hills 4
Borås 4
Busseto 4
Falls Church 4
Fremont 4
Fuzhou 4
Andover 3
Bari 3
Leawood 3
Massarosa 3
Modena 3
Pavia 3
Rockville 3
Sacramento 3
Brno 2
Candiac 2
Chongqing 2
Dong Ket 2
Forlì 2
Hong Kong 2
Houston 2
London 2
Mestre 2
Minerbio 2
Mola Di Bari 2
Redwood City 2
Reggio Emilia 2
Selvazzano Dentro 2
Xian 2
Adelaide 1
Almaty 1
Arcole 1
Bangalore 1
Baotou 1
Cambridge 1
Carlentini 1
Casalgrande 1
Casamarciano 1
Chengdu 1
Chiayi County 1
Fairfield 1
Fossalta di Piave 1
Genoa 1
Gorgonzola 1
Gouvieux 1
Grafing 1
Henderson 1
Huizen 1
Johannesburg 1
Kashan 1
Totale 2.173
Nome #
Involvement of HER-2/neu and metastasis-related proteins in the development of ileal neuroendocrine tumors 106
Isolation and Characterization of Circulating Tumor Cells in Squamous Cell Carcinoma of the Lung Using a Non-EpCAM-Based Capture Method 92
Classification of gastric endocrine cells at the light and electron microscopical levels 89
High levels of Notch intracellular cleaved domain are associated with stemness and reduced bevacizumab efficacy in patients with advanced colon cancer 89
Correlations between tumor-infiltrating and circulating lymphocyte subpopulations in advanced renal cancer patients treated with nivolumab 87
Human Papilloma Virus (HPV) status, P16INK4a and p53 overexpression in epithelial malignant and borderline ovarian neoplasms 86
Atrophic body gastriris patients with enterochromaffin-like cell dysplasia are at increased risk for development of type I gastric carcinoid 84
ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: prognostic evaluation by pathological analysis 83
p27: a potential main inhibitor of cell proliferation in digestive endocrine tumors but not a marker of benign behavior 79
REPEATED ANASTOMOTIC RECURRENCE OF COLORECTAL TUMORS. GENETIC ANALYSIS OF TWO CASES. 78
Impact of laterality and mucinous histology on relapse-free and overall survival in a registry-based colon cancer series 78
Genetic alterations in poorly differentiated endocrine carcinomas of the gastrointestinal tract 76
Effect of chronic hypergastrinemia on human enterochromaffin-like cells: Insights from patients with sporadic gastrinomas 75
Notch expression and bevacizumab efficacy in colorectal cancer patients 75
Histological subtype analysis of colon cancer: a population-based study. Different sides and different diseases. 72
Pleomorph poorly differentiated endocrine carcinoma of the rectum 71
P-027Cancer stem cells marker CD44 and Notch activation predict unfavorable prognosis in metastatic colon cancer patients treated with anti VEGF-therapy 71
Metaplastic papillary tumour of the salpinx: report of a case with microsatellite analysis 70
Strong Notch activation hinders bevacizumab efficacy in advanced colorectal cancer 70
The antral mucosa as a new site for endocrine tumors in Multiple Endocrine Neoplasia type-1 and Zollinger Ellison syndromes 69
Malignancy-associated allelic losses on X chromosome in foregut but not in midgut endocrine tumours 68
Distinct molecular patterns based on proximal and distal sporadic colorectal cancer: arguments for different mechanisms in the tumorigenesis. 67
YES1 and MYC Amplifications as Synergistic Resistance Mechanisms to Different Generation ALK Tyrosine Kinase Inhibitors in Advanced NSCLC: Brief Report of Clinical and Preclinical Proofs 66
Sporadic colorectal carcinomas with low-level microsatellite instability: a distinct subgroup with specific clinicopathological and molecular features. 65
REPEATED ANASTOMOTIC RECURRENCE OF COLORECTAL TUMORS. GENETIC ANALYSIS OF TWO CASES. 63
Adenomatous polyposis coli gene involvement in ileal enterochromaffin cell neuroendocrine neoplasms. 62
Primary Squamous Cell Carcinoma of the Endometrium Unrelated to Human Papilloma Virus: A Molecular Study 62
Reliability of EGFR and KRAS mutation analysis on fine-needle aspiration washing in non-small cell lung cancer 62
Cancer stem cells related marker CD44 and Notch activation in metastatic colon cancer patients 61
Potential predictive biomarkers in locally advanced rectal cancer treated with preoperative chemo-radiotherapy 60
Microsatellite instability in colorectal cancer 60
Intramucosal cysts in the gastric body of patients with Zollinger-Ellison syndrome 59
Pancreatic Polypeptide-related tumors 59
Concurrent Acquired BRAF V600E Mutation and MET Amplification as Resistance Mechanism of First-Line Osimertinib Treatment in a Patient with EGFR-Mutated NSCLC 59
Monitoring cfDNA in plasma and in other liquid biopsies of advanced EGFR mutated NSCLC patients: A pilot study and a review of the literature 59
P16INK4a overexpression independent of Human Papilloma Virus (HPV) infection in rare subtypes of endometrial carcinomas 57
Notch Activation Modulates Bevacizumab Activity by CD44 Positive Cancer Stem Cells in Advanced Colon Cancer 57
Different patterns of 11q allelic losses in digestive endocrine tumors 56
Emergence of a HER2-amplified clone during disease progression in an ALK-rearranged NSCLC patient treated with ALK-inhibitors: A case report 56
ANASTOMOTIC RECURRENCE OF COLON CANCER: GENETIC ANALYSIS CHALLANGES THE WIDELY HELD THEORIES OF CANCEROUS CELLS’ INTRALUMINAL IMPLANTATION AND METACHRONOUS CARCINOGENESIS 55
Surgical treatment of multiple sporadic colorectal carcinoma 55
Progression of gastric enterochromaffin-like cells growth in Zollinger-Ellison syndrome and atrophic body gastritis patients 54
Optimizing PD-L1 evaluation on cytological samples from advanced non-small-cell lung cancer 53
Two subtypes of mucinous adenocarcinoma of the colorectum: clinicopathological and genetic features 51
ERCC1/BRCA1 expression and gene polymorphisms as prognostic and predictive factors in advanced NSCLC treated with or without cisplatin 47
From the beginning to resistance: Study of plasma monitoring and resistance mechanisms in a cohort of patients treated with osimertinib for advanced T790M-positive NSCLC 47
Sampling strategies for analysis of enterochromaffin-like (ECL) cell changes in Zollinger-Ellison syndrome 45
Notch-Jagged1 signaling and response to bevacizumab therapy in advanced colorectal cancer: A glance to radiomics or back to physiopathology? 43
Thymidylate synthase, topoisomerase-1 and microsatellite instability: relationship with outcome in mucinous colorectal cancer treated with fluorouracil. 43
Resistance to osimertinib in advanced EGFR-mutated NSCLC: a prospective study of molecular genotyping on tissue and liquid biopsies 34
Impact of preoperative chemoradiotherapy on tumor infiltrating lymphocytes in locally advanced rectal cancer: The SMART-STAR study 30
Influence of preoperative chemoradiation on tumor-infiltrating lymphocytes in locally advanced rectal cancer: The STAR-01 cohort 27
Influence of preoperative chemoradiation on tumor-infiltrating lymphocytes in locally advanced rectal cancer: The STAR-01 cohort 23
Therapeutic Outcomes and Clinical Features of Advanced Non-Small Cell Lung Cancer Carrying KRAS Mutations: A Multicenter Real-life Retrospective Study 19
Multicenter Observational Study on Metastatic Non-Small Cell Lung Cancer Harboring BRAF Mutations: Focus on Clinical Characteristics and Treatment Outcome of V600E and Non-V600E Subgroups 4
Totale 3.388
Categoria #
all - tutte 12.146
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.146


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020652 93 98 28 17 45 87 63 12 38 127 12 32
2020/2021245 5 24 24 26 32 8 25 10 48 7 32 4
2021/2022279 6 1 4 18 13 8 42 24 16 17 34 96
2022/20231.232 106 155 66 96 101 146 12 85 393 14 43 15
2023/2024435 27 29 9 7 30 121 42 41 17 24 25 63
2024/202533 33 0 0 0 0 0 0 0 0 0 0 0
Totale 3.388